MILWAUKEE, Aug. 7, 2019 /PRNewswire/ -- Ademi &
O'Reilly, LLP is investigating Cambrex (NYSE: CBM) for
possible breaches of fiduciary duty and other violations of the law
in connection with the sale of Cambrex to Permira.
Click here to learn how to join the action:
http://ademilaw.com/case/cambrex or call Guri Ademi toll-free at 866-264-3995. There
is no cost or obligation to you.
Ademi & O'Reilly, LLP alleges Cambrex's financial outlook is
improving and yet shareholders will receive only $60 for each
share of Cambrex common stock they own. Permira is
acquiring Cambrex at a substantial discount. The merger
agreement unreasonably limits competing bids for Cambrex by
prohibiting solicitation of further bids, and imposing a
termination penalty if Cambrex accepts a superior bid. Cambrex
insiders will receive millions of dollars as part of change of
control arrangements. We are investigating on the conduct of
Cambrex's board of directors, and whether they are (i) fulfilling
their fiduciary duties to all shareholders, and (ii) obtaining a
fair and reasonable price for Cambrex.
If you own common stock in Cambrex and wish to obtain additional
information, please contact Guri
Ademi either at gademi@ademilaw.com or toll-free:
866-264-3995, or http://ademilaw.com/case/cambrex.
We specialize in shareholder litigation involving buyouts,
mergers, and individual shareholder rights throughout the country.
For more information, please feel free to call us. Attorney
advertising. Prior results do not guarantee similar outcomes.
Contacts
Ademi & O'Reilly, LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001
View original
content:http://www.prnewswire.com/news-releases/shareholder-alert-ademi--oreilly-llp-investigates-whether-cambrex-corporation-has-obtained-a-fair-price-in-its-sale-to-permira-funds-300898040.html
SOURCE Ademi & O'Reilly, LLP